REGN Sentiment Analysis
We collect and analyze sentiment surrounding REGN stock to help you make informed investment decisions.
Regeneron Pharmaceuticals Inc. Continues to Impress Investors with Strong Performance
Published on September 5, 2025
Regeneron Pharmaceuticals Inc....
Regeneron Pharmaceuticals: Revolutionizing Healthcare with Innovative Drug Approvals
Published on July 5, 2025
Regeneron Pharmaceuticals, Inc. recently made headlines with the approval of Dupixent by the US FDA, in collaboration with Sanofi....
Regeneron Pharmaceuticals Inc. Continues to Impress Investors as UBS Lowers Price Target
Published on June 27, 2025
Regeneron Pharmaceuticals Inc. has been making waves in the biotech industry, with impressive financial and operating results....
REGENERON PHARMACEUTICALS, INC. Hits Price Target Forecast with 33.76% Profit Margin
Published on June 5, 2025
QuantWave's forecast signal for REGENERON PHARMACEUTICALS, INC....
REGENERON PHARMACEUTICALS, INC. Hits Forecast Price Target with a 32.0% Profit
Published on June 5, 2025
REGENERON PHARMACEUTICALS, INC....
REGENERON PHARMACEUTICALS, INC. Hits QuantWave Price Target Forecast with 27.18% Profit
Published on June 4, 2025
REGENERON PHARMACEUTICALS, INC....
REGENERON PHARMACEUTICALS, INC. Hits Price Target Forecast with Profit of 26.25%
Published on June 4, 2025
REGENERON PHARMACEUTICALS, INC. stock recently achieved the price target forecast set by QuantWave on March 21, 2025....
REGENERON PHARMACEUTICALS, INC. Hits Price Target Forecast with 26.25% Profit: QuantWave's Success in Stock Prediction
Published on June 4, 2025
REGENERON PHARMACEUTICALS, INC. has recently reached the price target forecast set by QuantWave on June 4, 2025....
REGENERON PHARMACEUTICALS, INC. Hits QuantWave Price Target Forecast with 27.18% Profit
Published on June 4, 2025
REGENERON PHARMACEUTICALS, INC....
REGENERON PHARMACEUTICALS, INC. Hits QuantWave's Price Target with 20.42% Profit
Published on May 30, 2025
In a recent success story for QuantWave, the automated forecasting platform accurately predicted a short position for REGENERON PHARMACEUTICALS, INC. on April 1, 2025, when the stock was trading at $616.09. Fast forward to May 30, 2025, and the stock...
REGENERON PHARMACEUTICALS, INC. Stock Hits Price Target Forecast, Bringing 27.31% Profit
Published on May 30, 2025
On March 4, 2025, QuantWave, the automated forecasting platform, issued a short signal for REGENERON PHARMACEUTICALS, INC....
REGENERON PHARMACEUTICALS, INC. Hits 29.73% Profit Target as Forecasted by QuantWave
Published on May 30, 2025
REGENERON PHARMACEUTICALS, INC....
REGENERON PHARMACEUTICALS, INC. Hits Short Forecast Target with 17.43% Profit
Published on May 30, 2025
QuantWave's forecast signal for REGENERON PHARMACEUTICALS, INC. on July 1, 2022, predicted a short direction with a price of $593.76....
REGENERON PHARMACEUTICALS, INC. Hits Price Target Forecast with 21.51% Profit
Published on May 30, 2025
REGENERON PHARMACEUTICALS, INC....
REGENERON PHARMACEUTICALS, INC. Hits QuantWave Forecast Target with a Profit of 30.6%
Published on May 30, 2025
REGENERON PHARMACEUTICALS, INC. has successfully reached the price target forecasted by QuantWave, resulting in a profit of 30....
REGENERON PHARMACEUTICALS, INC. Hits Price Target Forecast with 34.08% Profit: A Success Story for QuantWave
Published on May 30, 2025
REGENERON PHARMACEUTICALS, INC....
REGENERON PHARMACEUTICALS, INC. Hits Price Target Forecast with 20.42% Profit Margin
Published on May 30, 2025
REGENERON PHARMACEUTICALS, INC....
REGENERON PHARMACEUTICALS, INC. Hits QuantWave Price Target Forecast with 34.08% Profit
Published on May 30, 2025
REGENERON PHARMACEUTICALS, INC. stock successfully reached the price target forecast set by QuantWave on May 30, 2025....
REGENERON PHARMACEUTICALS, INC. Hits 30.6% Profit Target as Forecasted by QuantWave
Published on May 30, 2025
REGENERON PHARMACEUTICALS, INC....
REGENERON PHARMACEUTICALS, INC. Hits Price Target Forecast With 21.51% Profit: QuantWave's Success
Published on May 30, 2025
REGENERON PHARMACEUTICALS, INC....
QuantWave Successfully Forecasts REGENERON PHARMACEUTICALS, INC. Stock Price, Achieving a Profit of 14.38%
Published on May 30, 2025
On April 4, 2025, QuantWave, an automated forecasting platform, issued a short signal for REGENERON PHARMACEUTICALS, INC....
REGENERON PHARMACEUTICALS, INC. Hits QuantWave Price Forecast with 17.43% Profit
Published on May 30, 2025
REGENERON PHARMACEUTICALS, INC. has successfully achieved the price target forecast set by QuantWave, resulting in a profit of 17....
REGENERON PHARMACEUTICALS, INC. Hits Price Target Forecast with 27.31% Profit
Published on May 30, 2025
REGENERON PHARMACEUTICALS, INC....
REGENERON PHARMACEUTICALS, INC. Hits Price Target Forecast with 29.73% Profit
Published on May 30, 2025
REGENERON PHARMACEUTICALS, INC. has achieved the price target forecast set by QuantWave on February 28, 2025....
REGENERON PHARMACEUTICALS, INC. Hits Price Target Forecast with 25.34% Profit Margin: A Victory for QuantWave
Published on May 9, 2025
REGENERON PHARMACEUTICALS, INC....